July 10, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
The Alzheimer’s Association International Conference 2026 will meet in London, with breakthrough research planned across workshops, lectures and plenary sessions. Laura Nisenbaum, PhD, interim chief science officer of the Alzheimer’s Drug Discovery Foundation, will be at the event, which runs from July 12 to July 15. Healio spoke with her about what she’s looking forward
July 10, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

/C O R R E C T I O N — Eli Lilly and Company/

Alzheon to Present New Evidence of Neurovascular Protection and Preserved Brain Microstructure from Oral Valiltramiprosate Trials in APOE4/4 Alzheimer’s Patients at AAIC 2026 Conference in London

Genentech and Roche Present New Data in Alzheimer’s Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC

Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment

Looking Ahead: The Future of Alzheimer's Disease Treatment

Clinical Trials on Alzheimer's Disease Conference and Alzheimer's Drug Discovery Foundation Partner to Advance Emerging Biotech…

In this Healio video, Christopher Lock, MD, discusses advances in Alzheimer’s disease treatment and diagnosis presented at the…

We are living in an exciting new era for Alzheimer’s treatment. For the first time, therapies can slow the disease for some…

Christopher Lock, MD, spoke with Healio about takeaways on the impact of lifestyle factors on Alzheimer’s disease presented at…

NeuroXT and BIDMC Expand Collaboration to Advance AI-Driven Precision Treatment in Alzheimer's Disease

In this Healio video, Christopher Lock, MD, discusses highlights in anti-amyloid therapies for Alzheimer’s disease presented at…